SAIC won the $95 million blanket purchase agreement known as the Advanced Research and Scientific Computing Support Services BPA.
The statement of work outlines how the BPA provides scientists and researchers a suite of “computationally intensive methods, high-performance computing, and cloud-based services” that center around large datasets.
GDIT is challenging the evaluation and best-value tradeoff method, arguing the FDA did not correctly calculate SAIC’s total evaluated price and ignored SAIC’s allegedly unbalanced pricing. Because of these factors, GDIT claims best-value tradeoff could not be properly established… Read the full article here.
